Follow the event on Twitter at: #CSCHealth19
LONDON, 19 November 2019 – Consilium Strategic Communications (“Consilium”), a global leader in strategic healthcare communications and investor relations, together with Citi, Cooley and Stifel, will host its seventh Annual Healthcare Conference today in London.
This invite-only annual event brings together senior representatives from across the international healthcare and investment sectors to share their insights on the most pressing topics impacting the industry today in a series of talks and panels, alongside excellent networking opportunities.
More than 350 delegates are registered from companies across Europe and the US, as well as investment experts and business development specialists. This year’s panels will look at the evolving nature of the relationship between biotech companies and big pharma, the current economic and fundraising environment as we look ahead to next year’s US election, and insights on future trends in the healthcare industry in an increasingly digital world.
The conference is taking place at a central London location and will run from 12pm, starting with lunch, and will conclude at 5pm followed by networking drinks, sponsored by Ford Sinclair.
Conference programme:
| 12:00pm – 1:00pm | Lunch and Networking |
| 1:00pm – 1:15pm | Welcome and Introductions |
| 1:15pm – 1:30pm | Keynote Speech by Shaun Grady, Senior Vice-President Business Development Operations, AstraZeneca |
| 1:30pm – 2:15pm | Biotech versus Big Pharma ‒ Who needs whom now? |
| We have assembled a panel that will discuss the evolving nature of the relationship between big pharma and small biotechs, especially as innovation in advanced therapies continues apace. Can biotechs build the scale needed to manage new treatment paradigms and negotiate pricing and reimbursement to bring these treatments to patients? Or is a buyout inevitable? Is big pharma nimble and innovative enough to drive such transformational science? We’ll find out more. | |
| Speakers:• Ben Adams, Editor, Fierce Biotech• Kate Bingham, Managing Partner, SV Health Investors• Sven Kili, Principal, Sven Kili Consulting• Dmitry Kuzmin, Managing Partner, 4BIO Capital• Jan Thirkettle, Chief Development Officer, Freeline | |
| 2:15pm – 3:00pm | Update on capital markets ‒ Is the US the promised land for healthcare financing? |
| This select group has been brought together for their depth of fundraising experience in the US, and we can expect a lively discussion on the dos and don’ts and pros and cons of various aspects of raising capital on the other side of the Atlantic – including the merits or otherwise of conducting a dual listing and whether to raise a crossover round – against the backdrop of a looming US election. | |
| Speakers:John Dawson, Chief Executive Officer, Oxford BiomedicaMichel Detheux, Chief Executive Officer, iTeos TherapeuticsEric Soyer, Chief Financial Officer & Chief Operating Officer, ERYTECH• Lisa Williams, EMEA Head of DR Investor Relations Advisory, Citi | |
| 3:00pm – 3:30pm | Break |
| 3:30pm – 4:15pm | Healthcare 2.0 ‒ What will the industry look like in 2020 and beyond? |
| Our panellists will look ahead to the coming year and next decade, discussing the challenges and trends they expect the healthcare sector to encounter as it strives to bring innovation and technology to patients. From advanced therapies to artificial intelligence to home-based care – what will drive investment trends and research priorities? When will patients see real change? | |
| Speakers:Doug Doerfler, President and Chief Executive Officer, MaxcyteRabia Khan, Chief of Translational Medicine, Sensyne HealthDarragh Lyons, Chief Executive Officer, MalinJosé Mesa, Partner, Alta Life Sciences• John Milad, Chief Executive Officer, Quanta | |
| 4:15pm – 5:00pm | Fireside chatInterviewer: Denise Roland, Pharmaceuticals Reporter, Wall Street JournalSpeaker: Sean Marett, Chief Business and Chief Commercial Officer, BioNTechIn this frank and insightful discussion, Sean and Denise will explore BioNTech’s route to a successful US listing, and the lessons learned and key takeaways from the journey. |
| 5:00pm – 6:00pm | Networking Drinks |
Mary-Jane Elliott, Managing Partner of Consilium Strategic Communications, commented: “Our annual Healthcare Conference is now firmly part of the international annual healthcare conference calendar and we are delighted to be hosting this year’s event alongside Citi, Cooley and Stifel. With a new decade almost upon us, we have created a forward-looking agenda with carefully selected panellists and speakers and, of course, a great audience to share the day with.
“2019 has been another exciting year of significant growth for Consilium. We have opened our first US office and further strengthened our team in both Europe and US with senior appointments. Consilium is well placed for its clients and prospects in 2020 and beyond, an era that is set to bring more positive impacts for patients yet challenges for our international healthcare industry. As always, we are hugely grateful to our clients and contacts for their continued support.”
